Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

12. Dezember 2022 10:00 ET | Quelle: Seer, Inc.

Seer’s Proteomics Platform Named as Top 10 Innovation in 2022 by The Scientist

REDWOOD CITY, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the...
08. November 2022 16:05 ET | Quelle: Seer, Inc.

Seer Reports Third Quarter 2022 Financial Results

REDWOOD CITY, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
13. Oktober 2022 16:15 ET | Quelle: Seer, Inc.

Seer to Report Third Quarter 2022 Financial Results on November 8, 2022

REDWOOD CITY, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report...
30. August 2022 16:05 ET | Quelle: Seer, Inc.

Seer to Participate in the Morgan Stanley Global Healthcare Conference

REDWOOD CITY, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company...
23. August 2022 08:00 ET | Quelle: Seer, Inc.

Seer Announces Publication of Seminal Study Demonstrating the Power of Engineered Nano-Bio Interactions to Enable Deep Access to the Proteome

REDWOOD CITY, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) today announced the publication of a study demonstrating the performance of the technology underlying the...
09. August 2022 16:05 ET | Quelle: Seer, Inc.

Seer Reports Second Quarter 2022 Financial Results

REDWOOD CITY, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
03. August 2022 09:00 ET | Quelle: Seer, Inc.

Seer Launches First-of-its-kind Proteogenomics Workflow to Link Genetic Changes with Protein Variants with Proteograph™ Analysis Suite 2.0

REDWOOD CITY, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced a new...
14. Juli 2022 16:05 ET | Quelle: Seer, Inc.

Seer to Report Second Quarter 2022 Financial Results on August 9, 2022

REDWOOD CITY, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report...
04. Mai 2022 16:05 ET | Quelle: Seer, Inc.

Seer Reports First Quarter 2022 Financial Results

REDWOOD CITY, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
28. April 2022 16:05 ET | Quelle: Seer, Inc.

Seer to Present at the BofA Securities 2022 Healthcare Conference

REDWOOD CITY, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company...

Vorherige Seite

Nächste Seite